Gene Query: JMJD1C

Dataset Description Geneva Score
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 81.79
A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II] 78.75
Transcriptome analysis in Neobractatin treated cells 56.88
Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways 47.69
Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment 45.88
The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth 43.59
Analysis of regulatory element evolution between human and mouse reveals a lack of cis-trans compensation 41.3
RNA-sequencing of human leukemia cells and mouse hematopoietic progenitors 40.97
Genetic and pharmacological restoration of TET2 function blocks stem cell self-renewal and progression of leukemia 40.97
VAMP8 contributes to TRIM6-mediated type-I interferon antiviral response upon West Nile virus (WNV) infection 40.45
‘Naïve’ ESRRB+ iPSCs with the capacity for rapid neural differentiation 39.7
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor 38.51
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 2h] 38.16
Genetic-to-epigenetic Therapy for Pancreatic Cancer 36.85
Gene expression changes in THP1 cells at day 2 and 4 following shRNA knock-down of RUVBL2 36.47
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 36.27
Gene expression changes upon drug withdrawal (Mel888 cell line) 34.93
An RNA-centric dissection of host complexes controlling flavivirus infection [RNA-Seq] 33.58
An RNA-centric dissection of host complexes controlling flavivirus infection 33.58
A Brain Penetrant Mutant IDH1 Inhibitor Provides In Vivo Survival Benefit 32.61
Interaction with WDR5 recruits MYC to a small cohort of genes required for tumor onset and maintenance 32.34
Gene expression analysis of dengue-infected cells 31.59
High-throughput RNA sequencing of human preovulatory cumulus and mural granulosa cells (mRNA) 31.3
Small RNA-seq of human granulosa cells reveals miRNAs in FSHR and aromatase genes 31.3
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq] 30.65
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 30.13
High capacity of the endoplasmic reticulum to prevent secretion and aggregation of amyloidgenic proteins 29.49
A Werner syndrome stem cell model unveils heterochromatin alterations as a driver of human aging 28.69
Tracking of dCas9-methyltransferase footprints 27.81
NAD+ Analog-sensitive PARPs Reveal a Role for PARP-1 in Transcription Elongation 27.75
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 27.69
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 27.07
Paxillin regulates genomic networks in prostate cancer [LNCaP] 26.85
Differential expression of long non‑coding RNA and mRNA in children with Henoch‑Schönlein purpura nephritis 26.19
RNASeq of MV4;11 cells transduced with scramble shRNA or BRD4 shRNA in combination with DMSO or SGC0946 25.62
TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality 25.11
RNA expression analysis upon JMJD1C depletion 25.06
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a co-activator for key transcription factors 25.06
TRIM28-Regulated Transposon Repression Is Required for Human Germline Competency and Not Primed or Naive Human Pluripotency 24.98
Genome-wide functional assessment of enhancer activities in the human genome 24.85
Transcriptional study of ARN8 cells treated with novel DHODH inhibitors 24.74
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 24.35
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A 24.16
RNASEQ Analysis of sh-TRC and sh-MIR100HG in the triplex negative breast cancer 24.04
ASCL1 mediates neuronal differentiation of primary GBM stem cell cultures upon Notch signalling blockade [RNA-seq] 23.27
Group A Streptococcus M1T1 Intracellular Infection of Primary Tonsil Epithelial Cells Dampens Levels of Secreted IL-8 Through the Action of SpyCEP 23.06
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity 23.0
RNA-Seq analysis of cSCC cells after siRNA-induced gene knockdown of lncRNA PRECSIT 22.63
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 22.32
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 22.31
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes 22.08
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 21.99
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 21.73
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 21.67
miRNAs affected by antagomiR-17 treatment 21.66
Comparative Analysis of the Transcriptome of Latent Autoimmune Diabetes (LADA) Patients from Eastern China 21.19
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition [RNA-Seq] 21.05
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition 21.05
ROR-γ drives androgen-receptor expression and represents a therapeutic target in castration-resistant prostate cancer 20.95
RNA sequencing (RNA-SEQ) of Human endothelial cells (HUVEC) in LFS, sFRP2OE, and WT conditioned media 20.81
Crizotinib v. DMSO in SW480 cells 20.7
Gene Expression Analysis of Melanoma Cells Treated with 6-Thio-dG In Vitro 20.63
hTERT promotes cell adhesion and migration independent of telomerase activity 20.61
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 20.56
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 20.03
High-throughput sequencing of PROMPT-enriched samples. 19.89
CRISPR-Cas9 combinatorial KO of epigenetic regulators in human ovarian cancer cells 19.8
Polyol pathway links glucose metabolism to the aggressiveness of cancer cells 19.79
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 19.66
RNA-Seq analysis of breast cancer cells after shikonin treatment 19.57
Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation 19.19
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 19.18
Uridylation by TUT4 and TUT7 marks mRNA for degradation 19.18
Whole-transcriptome profilings between a pair of HCA7-derived KRAS-wildtype cetuximab sensitive and resistant colon cancer cells from 3D culture 19.08
Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs 19.0
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 18.88
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 18.67
Bioinformatics analysis of transcriptome related to blood stasis syndrome in diabetes mellitus patients 18.64
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha 18.57
Human cell line and subcutaneous tumor 18.47
Role of COP1 on MAP kinase transcriptional output in gastrointestinal stromal tumor 18.44
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 18.38
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 18.06
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 18.06
Exogenous pyruvate represses histone gene expression to inhibit cancer cell proliferation via the NAMPT-NAD + -SIRT1 pathway 17.97
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 17.85
RNAseq to determine gene expression changes following depletion of SETDB1 in THP-1 AML Cells 17.72
Transcriptional Modulation of Human Endogenous Retroviruses in Primary CD4+ T Cells Following Vorinostat Treatment 17.71
Uridilation by TUT4/7 restricts retrotransposition of human Line-1s 17.66
Novel Form of JARID2 is Required to Regulate Differentiation in Keratinocytes. 17.59
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 17.35
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 17.3
Studying iPSCs from a hibernating mammal reveals molecular mechanisms of cold resistance in neural tissues 17.29
Genome-wide expression profiling of an in vitro model for studying esophageal epithelial differentiation 17.27
AMPK signaling for naïve pluripotency [Hs] 16.94
AMPK signaling for naïve pluripotency 16.94
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq B-ALL) 16.75
Impact of dieldrin on transcription in Jurkat T cells 16.55
CD95/Fas ligand mRNA is toxic to cells 16.43
RNA deep sequencing analysis of glioma stem cells(GSCs) and non-GSCs 16.32
Bach1 Regulates the Self-renewal and Mesendodermal Differentiation of Human Embryonic Stem Cells 16.31
miCLIP, RNA-Seq, and Ribo-Seq in MOLM13 cells 16.25
The regulartory role of ZCCHC24 in splicing machinery 16.18
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 16.1
Nuclear HNRNPA2B1 HITS-CLIP and RNA-seq 16.06
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with ENST00000431060 shRNA or control shRNA 16.01
Poly(A)-specific ribonuclease (PARN) mediates 3' end maturation of the telomerase RNA component 15.99
RNA-Seq following PCR-based sorting reveals rare cell transcriptional signatures 15.91
TCF21 and Aryl-hydrocarbon receptor gene cooperate to activate a pro-atherosclerotic gene expression program 15.58
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 15.56
Genes regulated by soluble guanylyl cyclase in VCaP prostate cancer cells 15.51
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 15.21
Lysine benzoylation is a novel histone mark [RNA-seq] 15.19
Lysine benzoylation is a novel histone mark 15.19
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) 15.17
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues 15.17
Gene expression profiling of human CD19+ B cells and EBV transformed lymphoblastoid cell lines (LCLs) 15.16
Genes significantly down or Up-regulated upon RNF219 knockdown 15.07
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells 15.07
RNA-Seq from early time points in the kidney differentiation protocol 14.97
Gene expression analysis of C4-2 cells treated with ACLY inhibitor and Enzalutamide 14.9
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway [RNA-Seq] 14.9
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway 14.9
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation 14.81
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation (Human_RWPE1_RNA-Seq) 14.81
RNA sequencing of mechanically strained NHEKs and control NHEKs 14.67
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs [GRO-seq II] 14.65
Role for citron kinase in prostate cancer growth 14.59
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 14.55
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 14.49
POLR3G Dependent PolyA+ and smallRNA Transcriptomes in Human Pluripotent Stem Cells 14.45
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 14.34
Distinct regulatory programs for Sox9 in transcriptional regulation of the developing mammalian chondrocyte 14.31
Distinct regulatory programs for Sox9 in transcriptional regulation of the developing mammalian chondrocyte [RNA-seq] 14.31
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 14.27
RNA-seq analyses of human prostate cancer cells 14.27
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 14.21
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 14.13
Inhibition of the Aryl Hydrocarbon Receptor - Polyamine Biosynthesis Axis Suppresses Multiple Myeloma and prostate cancer progression 14.06
Hierarchy of mono- and bi-allelic TP53 alterations in Multiple Myeloma cell fitness 13.97
Analysis of transcriptional regulation by Myt1 and Myt1l 13.87
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 13.75
Transcriptomes of oxLDL exposed trained monocytes 13.74
oxLDL exposed trained monocytes 13.74
Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone 13.73
Canonical poly(A) polymerase activity promotes the decay of a wide variety of mammalian nuclear RNAs 13.7
Transcription elongation regulates genome 3D structure 13.65
A global identification of PUM1 and PUM2 mRNA targets and their protein cofactors in human seminoma TCam-2 cells 13.64
Next generation sequencing on knockdown of AC093323.3 in lung cancer cells 13.57
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells 13.55
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 13.53
The dynamic landscape of coding and non-coding RNAs in the innate immune response to microbial pathogens 13.41
Differential analysis of gene regulation at transcript resolution by RNA-Seq 13.4
Differential analysis of HOXA1 in adult cells at isoform resolution by RNA-Seq [Illumina] 13.4
LncRNA-GAS5 negative regulation of YAP-target genes expression 13.39
mRNA expression data from human parthenogenetic haploid ESCs (hPGES), normal ESCs (H9) and human fibroblast 13.36
Genomic analysis of human parthenogenetic haploid ESCs (hPGES), normal human ESCs(H9) and human forskin fibroblast 13.36
Ribosomal footprinting of CN34-Parental and CN34-LM1a 13.32
Changes in human endometrial gland transcriptome over the window of implantation 13.18
Reversible LSD1 Inhibition with HCI-2509 induces the p53 gene expression signature in high-risk neuroblastoma cells 13.16
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 13.09
The contribution of Alu exons to the human proteome 13.06
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer [RNA-Seq] 12.99
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer 12.99
Hit-and-run' programing of CAR-T cells using mRNA nanocarriers 12.97
Changes in chromatin accessibility and gene expression induced by overexpression of ONECUT transcription factors 12.96
Profiling of gene expression using RNA-Seq in fibroblasts, iPSCs, iPSC-derived neurons and cells overexpressing Onecut transcription factors 12.96
Role of COP1 on MAP kinase transcriptional output in melanoma 12.95
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [RNA-Seq] 12.93
Codon usage optimization in pluripotent embryonic stem cells [tRNA sequencing] 12.87
Identification of HOXB13 target genes responsive to BET inhibitors 12.85
Ribosomal footprinting of MDA-Parental and MDA-LM2 12.84
UBL5 is essential for pre-mRNA splicing and sister chromatid cohesion in human cells 12.83
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 12.76
Alternative splicing of differentiated myeloid cell transcripts after infection by Anaplasma phagocytophilum impacts a selective group of cellular programs 12.58
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 12.55
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 12.46
Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia 12.38
RNA-seq analysis to identify the genes regulated by p53-SET interplay 12.33
ARID1A and ARID1B loss in HCT116 cells 12.32
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress 12.3
Genome-Wide Transcriptional Effects of the Anti-Cancer Agent Camptothecin 12.28
Post-transcriptional manipulation of TERC reverses molecular hallmarks of telomere disease 12.24
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 12.21
JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors 12.19
FMRP facilitates the nuclear export of N6-methyladenosine-containing mRNAs 12.19
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 12.19
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 12.19
RNA-sequencing in irradiated and normal A549 cells. 12.15
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 12.09
ERK potentiates transactivation and oncogenic function of ERG by phosphorylation induced dissociation of PRC2 complex 12.07
Global Mapping of Human RNA-RNA Interactions 12.04
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells 12.03
MYOD Gene Expression Regulation during Myogenic Conversion of Fibroblasts 11.95
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 11.78
RNA-Seq with and without RNase treatment in PCa cell lines 11.77
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 11.66
Gene expression changes caused by KRAS in MCF-10A 11.66
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition 11.65
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition [CAGE] 11.65
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome 11.64
Vitamin d receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy 11.63
Identification of metabolically distinct adipocyte progenitor cells in human adipose tissues 11.54
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers (RNA-Seq) 11.5
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers 11.5
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 11.5
Proteolytic cleavage by taspase1 and the regulation of the stability of MLL1 11.48
Reprogramming by de-bookmarking somatic transcriptional program via targeting the BET bromodomains 11.38
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition 11.32
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition [RNA-Seq] 11.32
Transcriptome profiling of CXCR2+ neuroendocrine (NE) tumor cells purified from patients' fresh prostate adenocarcinoma 11.31
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 11.25
Modeling CADASIL vascular pathologies with patient-derived induced pluripotent stem cells 11.18
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 11.14
Dissecting the dynamics of signaling events in the BMP,WNT and NODAL cascade during self-organized fate patterning in human gastruloids 11.14
Genome-wide analysis of ferroptosis related genes in liver cancer cells. 11.11
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 11.03
Transcriptional landscape changes during human embryonic stem cell derivation 10.87
Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing 10.85
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages 10.77
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages (RNA-Seq, CAGE and ChIP-Seq) 10.77
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] 10.77
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line 10.77
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 10.72
NRDE2 negatively regulates nuclear exosome functions 10.52
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 10.5
Gene expressions of H9s in different culture systems 10.5
Differentially expressed genes post knock down of lincDUSP26 10.49
mRNA Sequencing of Human PromoCells Using 3'-directed Digital Gene Expression (3'-DGE) Technique 10.36
Transcriptomic profiles of human foreskin fibroblast cells in response to orf virus 10.35
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 10.27
Defective structural RNA processing in relapsing-remitting multiple sclerosis 10.26
MYOD Remodeling of the Genome Architecture during Myogenic Conversion of Somatic Cells 10.15
Widespread backtracking by RNA pol II is a major effector of gene activation, 5’ pause release, termination and transcription elongation rate 10.13
Solid phase chemistry to covalently and reversibly capture thiolated RNA 10.11
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction 10.09
AUF-1 affected genes in human skin cells 10.05
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming 10.03
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming (RNA-seq fibroblasts) 10.03
Comprehensive molecular phenotypic effects of the large deletion on chromosome 22q11.2 9.88
Unique features and clinical importance of acute alloreactive immune responses 9.76
Next Generation Sequencing Facilitates Quantitative Analysis of colorectal cancer cells transfected with NC siRNA or RPL9 siRNA 9.75
Gene expression profiling of LNCaP cells following shRNA-mediated knockdown of TMEFF2 and growth in presence and absence of dihydrotestosterone 9.73
Recovery and analysis of nascent RNA 9.67
The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains 9.67
Transcriptome profiling of H1-iCas9 cells grown on laminin and on MEFs 9.66
PER2 synchronizes mitotic expansion and decidual transformation of human endometrial stromal cells 9.63
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells 9.62
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells [RNA-seq] 9.62
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens [RNA-Seq] 9.61
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens 9.61
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 9.59
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 9.53
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray [RNA-Seq] 9.53
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray 9.53
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_human] 9.52
The ribonuclease activity of SAMHD1 is required for HIV-1 restriction 9.29
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 9.28
IGF2BP3 controls cancer cell invasiveness by modulation RISC function 9.25
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 9.23
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 9.23
The transcriptomic landscape of MAIT cell development in the thymus (NN41 RNAseq data set) 9.16
Gene expression comparison of resting human peripheral-blood NK cells and activated counterparts 9.06
Improved post thaw function and genetic changes for mesenchymal stromal cells cryopreserved using multicomponent osmolyte solutions 8.98
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 8.96
ETS1 acts as a tumor suppressor in breast cancer by inhibiting growth-related factors 8.92
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells [RNA-seq] 8.85
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells 8.85
FOXA1 Chromatin Binding is Regulated by LSD1-Mediated Demethylation 8.84
RNA-Seq with DHT induction and/or GSK treatment at 24, 48 hrs and 2 weeks 8.84
MYCL and EP400 are required for Max and MCPyV mediated gene activation 8.78
K562 polyA RNA-Seq 8.76
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 8.66
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 8.66
RNA-sequencing of human mammary epithelial cells (HMLEs) engineered to express either ER or ER-SOX4 with and without 4-OHT to induce nuclear translocation 8.63
RNA-sequencing experiment: Treatment of MCF-7 breast cancer cells with the novel small molecule ZNA 8.6
Differential gene expressions in the heart of hypertrophic cardiomyopathy patients 8.53
Regulation of poly(A) tail and translation during the somatic cell cycle 8.52
Capturing the Interactome of Newly Transcribed RNA 8.45
Capturing the Interactome of Newly Transcribed RNA (RICK) 8.45
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 8.45
Dysregulated immune system networks in war veterans with PTSD 8.3
The NFkB subunit RELA is a master transcriptional regulator of the committed epithelial-mesenchymal transition in airway epithelial cells 8.27
Expression data from miR340 overexpressing human A549 cells 8.2
RNA-sequencing time course of Human Intestinal Epithelial Cells (HIECs) following knockdown of miR-30bcd using complementary locked nucleic acids 8.15
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 8.1
Indoxyl sulfate stimulates angiogenesis by regulating reactive oxygen species production via CYP1B1 8.1
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 8.04
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation [RNA-seq] 8.0
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation 8.0
Transcriptomic Analysis of Endothelial Cells from Fibrovascular Membranes in Proliferative Diabetic Retinopathy 8.0
Effects on gene expression of doxorubicin in human stem cells-derived cardiomyocytes 7.93
Generation of KRAS signatures using immortalized isogenic lung cells. 7.88
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer 7.78
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer [RNA-Seq] 7.78
Functional role of CPPED1 in trophoblasts. 7.74
RNA polymerase in pre-B-ALL cell lines 7.49
HuR controls apoptosis and activation response without effects on cytokine 3′ UTRs 7.4
RNA-sequencing of highly pure synovial tissue macrophages reveals two distinct osteoarthritis subgroups that indicate different disease mechanisms. 7.22
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation (RNA-seq data) 7.16
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation 7.16
Subcellular RNA fractions of HSV-1 infected primary human fibroblasts 7.15
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells 7.09
Effect of drugs on transcriptomic profiles 7.04
Circular RNA expression signature of low-glucose-treated MIA PaCa-2 cells 7.03
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 6.92
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 6.92
Zone dependent distinctive gene expression profile of the normal human liver tissue 6.82
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 6.81
Apolipoprotein E4 Expression Causes Gain of Toxic Function in Isogenic Human Induced Pluripotent Stem Cell-Derived Endothelial Cells 6.81
Human naïve pluripotent stem cells exhibit X chromosome dampening and X-inactivation (RNA-Seq) 6.72
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 6.71
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 6.7
Tricyclic Antidepressants Induce Inactivation of Hepatic Stellate Cell (HSC) Myofibroblasts 6.68
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network with PRC2 [RNA-seq] 6.63
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network 6.63
scRNASeq analysis of cycling cardiomyocytes 6.62
Expression analysis of THP1 cells following shRNA knock-down of RUVBL2 6.59
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 6.57
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 6.51
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 6.51
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. 6.43
Identification of differentially spliced genes by wild type or S34F mutation of U2AF1 6.43
p63 controls the enhancer landscape during keratinocyte differentiation 6.4
HDAC and NFκB antagonists synergistically inhibit growth and metastatic dissemination of MYC-driven medulloblastoma 6.38
Transcriptome profiling identified a 3-lncRNA regulatory network in transthyretin against glucose induced hRECs dysfunction 6.37
Exploring ILF2 regulatory genes by next-generation sequencing 6.33
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 6.21
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_KD] 6.07
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 5.95
ChIPseq and RNAseq analysis of T47D cells with/without silencing TRPS1/CHD4 5.85
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment 5.82
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment [RNA-Seq] 5.82
Aortic Valve Tissue: Stenosis vs. Sclerosis 5.77
JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemias 5.62
Comparative gene expression profiling of MHH-CALL4 cells subject to pharmacological JAK2 inhibitor treatment (ruxolitinib or CHZ868) or shRNA-mediated JAK2 depletion in vitro 5.62
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 5.59
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 5.56
Gene expression analysis of human hepatocellular cancers 5.54
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [H1 RNA-seq] 5.52
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer 5.48
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer (RNA-Seq) 5.48
Comparative genome-wide analysis of human BM IL3Rα-high precursors show a more MΦ-, DC- and OC committed gene expression profile, as compared to IL3Rα-low precursors 5.47
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [RNA-Seq III] 5.36
Endothelial gene expression analysis 5.21
Total RNA deep sequencing (ribosomal depleted) of human umbilical vein endothelial cells exposed to hypoxia (0.2%) for 12h and 24h or kept under normoxic conditions. 5.21
Intrinsic Plasma Cell Differentiation Defects in BENTA Patient B cells 5.19
Gene Expression Analysis of HUVEC Seeded rBEL Contructs at Low and High Phases of Glucose Consumption 5.18
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 5.16
Human neutrophil genome during PMA- and E. coli encounter-induced activation 5.12
RNA-seq profiling of the human neutrophil genome during PMA- and E. coli encounter-induced activation 5.12
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition [RNA-Seq] 5.01
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition 5.01
Simultaneous profiling of sexually transmitted bacterial pathogens, microbiome, and concordant host response in cervical samples using whole transcriptome sequencing analysis 4.94
Inhibition of Enhancer of Zeste Homologue 2 attenuates TGF-β dependent hepatic stellate cell activation and liver fibrosis 4.9
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 4.89
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 4.78
RNA-sequencing analysis of glucose and acetate regulated transcripts in glioblastoma cells 4.7
Pain-driven transcriptome changes in synovium of knee osteoarthritis patients 4.67
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression [RNA-Seq] 4.62
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression 4.62
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 4.62
RNA-seq of Human neck of femur (NOF) fracture hip and osteoarthritic (OA) cartilage 4.59
Long noncoding RNA ROCR contributes to SOX9 expression and chondrogenic differentiation of human mesenchymal stem cells 4.59
UV_24h_GRO-Seq 4.49
Sex differences in transcriptomic profiles in aged kidney cells of renin lineage 4.46
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 4.3
Impact of GDF15 expression of ovarian cancer cell on stroma and Cisplatin responses 4.27
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 4.22
RNA-seq analysis of human KMT2A rearranged MV4;11 AML cell line treated with DOT1L and/or EZH2 inhibitor 4.1
Identification of differential expressed genes of JQ1 or JQ1+Bortezomib in colorectal cancer cells 4.04
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 3.96
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 3.96
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 3.92
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq] 3.91
Gene expression profiles of rescue with wild type or SUMO double mutant TRIM24 3.7
Transcriptome analysis of peripheral blood monocytes 3.7
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation 3.66
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 3.59
TGF-b-activated LncRNA LINC00115 is a critical regulator for glioma stem-like cell tumorigenicity 3.42
RNA sequencing of prostate cancers reveal insights on the prognostic significance of visibility on multi-parametric MRI 3.36
RNA-seq analysis of control and Myc-induced U2OS cells 3.34
Re-Wiring 3D Nuclear Architecture by a Single Transcription Factor during Somatic Cell Reprogramming 3.34
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 3.3
lncRNA expression analysis in patients with eosinophilic and neutrophilic asthma 3.27
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 3.24
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 3.23
Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. 3.22
Metastasis in triple-negative breast cancer 3.22
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 3.2
Functional characterization of human T cell hyporesponsiveness induced by CTLA4-Ig 3.17
Aneuploidy-induced cellular stresses limit autophagic degradation. 3.15
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 3.14
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 3.11
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 3.11
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq AML development) 3.11
HMGA1 and FOXM1 synergistically regulate a common gene network modulating angiogenesis in breast cancer 3.06
Anaylsis of the effect of down-regulation of the EWS-FLI1 fusion protein in Ewing Sarcoma cells by RNA-seq. 3.03
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 3.02
Diarrhea in lymphocytic colitis: ERK1/2-dependent ENaC dysregulation and claudin-4-, -5- and -8-related barrier defects 3.02
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation [RNA_Chondroblastoma_H3K36M_H3WT] 2.99
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation 2.99
Tracking transcriptional changes in a species-specific manner during experimental hepatoblastoma progression in vivo 2.99
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 2.94
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 2.94
Gene expression changes due to PARP knockdown in human cells 2.92
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 2.9
EPCR Expression Defines the Most Primitive Subset of Human HSPC and Is Required for Their In Vivo Activity 2.88
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and SMAD4 Y95 Mutation Transcriptomes 2.86
Ribosome profiling of TGFb-treated cells indicates reduced leucine availability 2.81
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains 2.58
Programmable RNA N6-methyladenosine editing by CRISPR-Cas9 conjugates 2.56
Comprehensive Transcriptome Analysis of Cerebral Cavernous Malformation Across Multiple Species and Genotypes 2.52
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) [RNA-seq] 2.47
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) 2.47
The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC derived cardiomyocytes. 2.45
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 2.39
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 2.39
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 2.37
Expression profile of MM.1S tumors folloiwing treatment with bortezomib 2.36
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 2.34
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 2.29
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 2.29
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 2.24
Temporal comparison of transcriptomic alterations in human, mouse and rat primary B lymphocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 2.22
RNA-Seq of PRMT1 overexpression ECA109 cells 2.21
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 2.18
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 2.18
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes (RNA-Seq) 2.16
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes 2.16
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 2.06
WNT signaling memory is required for ACTIVIN to function as a morphogen 2.04
RNA-Seq analysis of prostate cancer cell line LNCaP treated with vehicle, androgen, androgen and IMTPPE, androgen and JJ-(+)-450, androgen and JJ-(-)450, androgen and enzalutamide 1.98
Dynamic gene expression in T-ALL following treatment and release of gamma-secretase inhibition [GRO-Seq] 1.97
Subcellular pathways shared by afflicted patients and mutant mice identify a new drug treatment for aortic aneurysm in Marfan syndrome 1.97
Identification of miR-100 and miR-125b targets by AGO2 RIP-seq and RNA-seq after ectopic expression of miR-100 or miR-125b and evaluation of the TGFb expression signature in PANC-1 cells by RNA-seq 1.95
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 1.95
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 1.93
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 1.89
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 1.89
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma 1.87
Transcriptome-wide identification of transient RNA G-quadruplexes in human cells 1.84
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 1.77
Peripheral whole blood mRNAs and lncRNAs expression analysis in eosinophilic asthmatics 1.75
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 1.74
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors [Modifications - screen] 1.71
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 1.66
A comprehensive gene expression analysis identifies novel immune signatures in cesarean-born infants 1.61
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 1.58
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-PBS / R-2HG treatment 1.52
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 1.48
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 1.44
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 1.44
Aneuploidy triggers an immune response 1.4
RNA seq comparison between scrambled and shGRP78 cells 1.36
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 1.26
Uridylation by TUT4 and TUT7 marks mRNA for degradation [RNA-Seq] 1.2
Longitudinal transcriptome profiling of post-treatment Lyme disease syndrome 1.19
SOX11 knockdown in B-ALL cell lines 1.18
Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants 1.18
Characterization of EZH2-deficient human embryonic stem cells [ChIP-seq and bulk RNA-seq] 1.04
Effects of transcription on genome - nuclear lamina interactions: RNA-seq data 1.03
Effects of transcription on genome - nuclear lamina interactions 1.03
Determining mRNA half-lives on a transcriptome-wide scale 0.96
RNA-Seq analysis of proliferating 4N and 2N RPE1 cells derived from single cell clones following inhibition of Aurora B to induce polyploidization [tpo10] 0.95
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 0.77
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.7
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation [RNA-seq] 0.66
Insulin induced alterations in chromatin acetylation and transcriptome in triple negative breast cancer cells 0.64
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 0.6
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  0.6
Sex-specific gene expression differences are evident in human embryonic stem cells and during in vitro differentiation of human placental progenitor cells 0.53
The role of the Calcium-Sensing receptor in colorectal cancer 0.5
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 0.48
RNA-Seq of CD34+ Bone Marrow Progenitors from Healthy Donors 0.43
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs 0.42
Combined use of astragalus polysaccharide and berberine attenuates insulin resistance in IR-HepG2 cells via regulation of the gluconeogenesis signaling pathway 0.41
EGR1-controlled transcriptome of T HESCs 0.38
Transcriptome analysis of fetal Klinefelter testis tissue samples compared to controls 0.37
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 0.27
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 0.27
Concomitant BCORL1 and BRAF mutations in vemurafenib-resistant melanoma cells 0.24
JunB control of keratinocyte-mediated inflammation [RNA-seq] 0.24
RNA-Seq and ChIP-Seq reveals SQSTM1/p62 as a key mediator of JunB suppression of NF-kB-dependent inflammation 0.24
Irf9 function in immunity in mouse 0.18
Transcription profile analysis of wild type and Irf9-/- human monocytic THP1 cells in response to type I interferons 0.18
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 0.16
ADAR1-editing of cellular and measles virus-derived duplex RNA 0.16
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma 0.12
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] 0.12
Expression analysis of the TAF1 syndrome 0.12
RNA-Seq of human induced pluripotent stem cell-derived cardiomyocytes from a cardiomyopathy patient and familial control 0.11
System-wide profiling of RNA-binding proteins uncovers key regulators of virus infection 0.09
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 0.09
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.08
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p 0.07
A code of mono-phosphorylation modulates the function of RB. 0.04
RNA-Seq profiling in PBMCs and spinal cord from ALS patients and healthy controls 0.03
Comprehensive RNA-Seq profiling in PBMCs of ALS patients and healthy controls 0.03
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation